The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 4 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 4 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases.…”

Supplementary Material for: Scleroderma Secondary to Pembrolizumab: A Case Report and Review of 19 cases of anti PD-1-induced scleroderma. by Farrugia S. (16880841)

“…Immune checkpoint inhibitors are increasingly being used to treat various malignancies. …”

Dynamic coefficients between daily new COVID-19 cases per 1 million population and Type 1, 2, or 3 mobility metrics. by Weiyu Luo (4782711)

Subjects:

P-values of the dynamic coefficients between daily new COVID-19 cases per 1 million population and Type 1 mobility metrics. by Weiyu Luo (4782711)

Subjects:

S1 Data - by Nádia Cristina Pinheiro Rodrigues (9867386)

Subjects:

Scaled, pairwise relative Weighted Interval Score (rWIS; see <i>Methods</i> for description) by location for national and state/territory/DC forecasts, averaged across all horizons... by Velma K. Lopez (18510171)

Clinical characteristics of COVID-19. by Polrat Wilairatana (50854)

Subjects:

Associations between demographic factors and IPC practices and COVID-19 infection. by Ala Bin Tarif (13020471)

Subjects:

Scaled, pairwise relative Weighted Interval Score (rWIS) (see <i>Methods</i> for description) by spatial scale for sets of team forecasts that submitted forecasts for the US nation... by Velma K. Lopez (18510171)

Maternal Deaths from COVID-19 in Brazil: Increase during the Second Wave of the Pandemic by Carlos André Scheler (13253751)

An epidemic curve of the incidence of COVID-19 cases within medical laboratory services staff compared to the general South African population. by Kerry Sidwell Wilson (12890013)

Subjects:

Percent of weeks with complete submissions for all sets of team forecasts, scaled, pairwise relative Weighted Interval Score (rWIS; see <i>Methods</i> for description), observed 95... by Velma K. Lopez (18510171)

COVID-19 cases from May 2021-May 2022 in Georgia, US. by Ludy R. Carmola (20978107)

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 2 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 1; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 1 while <i>SD</i> increases; 11^<i>th</i> scenario, <i>ρ</i> = 0.75 in all Phase 2; 12^<i>th</i> scenario, <i>ρ</i> = 0.75 while <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 2 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 1; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 1 while <i>SD</i> increases; 11^<i>th</i> scenario, <i>ρ</i> = 0.75 in all Phase 2; 12^<i>th</i> scenario, <i>ρ</i> = 0.75 while <i>SD</i> increases.…”

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 3 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 2; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 2 while <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 3 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 2; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 2 while <i>SD</i> increases.…”

The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases. by Sara K. Al-Harbi (12418482)

“…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1^<i>st</i> scenario, no lockdown is implemented; 2^<i>nd</i> scenario, no lockdown while <i>SD</i> increases; 3^<i>rd</i> scenario, lockdown increases; 4^<i>th</i> scenario, <i>SD</i> increases; 5^<i>th</i> scenario, lockdown decreases; 6^<i>th</i> scenario, <i>SD</i> decreases; 7^<i>th</i> scenario, lockdown and <i>SD</i> increases; 8^<i>th</i> scenario, lockdown decreases and <i>SD</i> increases; 9^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5; 10^<i>th</i> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases.…”

A comparison of daily cases to swab positivity as measured by REACT-1. by Oliver Eales (11495186)

Subjects:

Choroidal thickness changes in post-COVID-19 cases by Şerife Gülhan Konuk (12684633)

“…Methods: This study evaluated the right eyes from 41 post-COVID-19 cases (Group 1) and 41 healthy subjects (Group 2). …”

Choroidal thickness changes in post-COVID-19 cases by Şerife Gülhan Konuk (12684633)

“…Methods: This study evaluated the right eyes from 41 post-COVID-19 cases (Group 1) and 41 healthy subjects (Group 2). …”

Bivariate analysis of socio-demographic characteristics of cases and controls. by Maja Stosic (18176616)

Subjects: